NCT06773858
- Conditions
- Adenocarcinoma, Carcinoma, Genital Diseases, +13 more
- Locations
-
- Karolinska Institutet Stockholm, Stockholm County, Sweden
Clinical trial condition
Adenocarcinoma
Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.
434 public trials
103 recruiting studies
Adenocarcinoma trial results
NCT03153410
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
NCT03535727
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Disease, +13 more
- Locations
-
- Sidney Kimmel Comprehensive Cancer Center Baltimore, Maryland, United States
NCT04028479
- Conditions
- Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma, +249 more
- Locations
-
- Teton Cancer Institute Idaho Falls, Idaho, United States
- Oncology and Hematology of South Texas Laredo, Texas, United States
NCT06726070
- Conditions
- Adenocarcinoma, Benign Prostate Hypertrophy(BPH), Carcinoma, +14 more
- Locations
-
- Alanya Alaaddin Keykubat University Training and Research Hospital Antalya, Turkey (Türkiye)
NCT04989816
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Diseases, +10 more
- Locations
-
- Research Site Beijing, China
- Research Site Beijing, China
- Research Site Changsha, China
- Research Site Chengdu, China
NCT01010945
- Conditions
- Adenocarcinoma, Advanced Pancreatic Cancer, Carcinoma, +3 more
- Locations
-
- Desert Comprehensive Cancer Center Palm Springs, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- University of North Carolina Chapel Hill, North Carolina, United States
- Fox Chase Cancer Center Philadelphia, Pennsylvania, United States
NCT04086758
- Conditions
- Adenocarcinoma, Carcinoma, Gastric or Gastro-esophageal Junction (GEJ) Adenocarcinoma, +3 more
- Locations
-
- Site CN86001 Guangzhou, China
NCT01969578
- Conditions
- Adenocarcinoma, Bulbo-Spinal Atrophy, X-Linked, Carcinoma, +22 more
- Locations
-
- Medical University Vienna - General Hospital AKH Vienna, Austria
- ZNA Middelheim Antwerp, Belgium
- Hopitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
- Cliniques Universitaires Saint-Luc Brussels, Belgium
Completed
Evaluate Mesothelin as a Biomarker for the Clinical Management of Esophageal Adenocarcinoma (EAC)
NCT01393483
- Conditions
- Adenocarcinoma, Carcinoma, Digestive System Diseases, +11 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States